Cargando…

FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma

Oral squamous cell carcinoma (OSCC) is one of the most common malignancies of the head and neck. In OSCC patients, the prognosis was dramatically different. In this research, we aimed to study the expressions and prognostic values of IgG Fc binding protein (FCGBP) in OSCC patients. The expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Ting, Zhang, Jianying, Wang, Yali, Liu, Binjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207623/ https://www.ncbi.nlm.nih.gov/pubmed/35733916 http://dx.doi.org/10.1155/2022/8443392

Ejemplares similares

FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma
por: Yan, Tengfeng, et al.
Publicado: (2022)

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Zhang, Shirong, et al.
Publicado: (2022)

Multi-Omics Analyses to Identify FCGBP as a Potential Predictor in Head and Neck Squamous Cell Carcinoma
por: Lin, Yu-Hsuan, et al.
Publicado: (2022)

Fcgbp – A Potential Viral Trap in RV144
por: Schwartz, Jacquelyn L
Publicado: (2014)

Transcriptomic analysis reveals an association of FCGBP with Parkinson’s disease
por: Gómez-Garre, Pilar, et al.
Publicado: (2022)

FcGBP was upregulated by HPV infection and correlated to longer survival time of HNSCC patients
por: Wang, Yating, et al.
Publicado: (2017)

Role of the mucin-like glycoprotein FCGBP in mucosal immunity and cancer
por: Liu, Qiao, et al.
Publicado: (2022)

Searching the Evolutionary Origin of Epithelial Mucus Protein Components—Mucins and FCGBP
por: Lang, Tiange, et al.
Publicado: (2016)

A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer
por: Wang, Kai, et al.
Publicado: (2021)

GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer
por: Shi, Yan-long, et al.
Publicado: (2022)

Biomarkers for Immunotherapy of Oral Squamous Cell Carcinoma: Current Status and Challenges
por: Almangush, Alhadi, et al.
Publicado: (2021)

Notch2 as a promising prognostic biomarker for oesophageal squamous cell carcinoma
por: Wang, Cong, et al.
Publicado: (2016)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

Midkine as a prognostic biomarker in oral squamous cell carcinoma
por: Ota, K, et al.
Publicado: (2008)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

Glut-1 as a prognostic biomarker in oral squamous cell carcinoma
por: Harshani, Jyotsna M, et al.
Publicado: (2014)

Different Forms of TFF3 in the Human Saliva: Heterodimerization with IgG Fc Binding Protein (FCGBP)
por: Houben, Till, et al.
Publicado: (2019)

PLODs: Novel prognostic biomarkers and potential immunotherapy targets for head and neck squamous cell carcinoma
por: Gong, Siming, et al.
Publicado: (2023)

Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population
por: Du, Hailei, et al.
Publicado: (2021)

GABRP is a Promising Prognostic Biomarker and Associated with Immune Cell Infiltration in Lung Squamous Cell Carcinoma
por: Fu, Jiding, et al.
Publicado: (2023)

Identification and validation of potential novel biomarkers for oral squamous cell carcinoma
por: Zhang, Mengxue, et al.
Publicado: (2021)

p-S6 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma
por: Delgado, Leonor, et al.
Publicado: (2022)

Prognostic value of inflammatory biomarkers in aged patients with oral squamous cell carcinoma
por: Yoshimura, Takuya, et al.
Publicado: (2022)

BUBR1 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma
por: Delgado, Leonor, et al.
Publicado: (2022)

NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma
por: Arora, Rahul, et al.
Publicado: (2023)

NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma
por: Yu, Xin, et al.
Publicado: (2023)

Macrophage migration inhibitory factor: A promising oncogenic serological biomarker for oral squamous cell carcinoma
por: Zepeda-Nuño, José Sergio, et al.
Publicado: (2021)

Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma
por: Tsai, Tsung-You, et al.
Publicado: (2022)

A198 COLONIC MUC2 MUCIN IS STABILIZED BY FCGBP TO RESIST SALMONELLA TYPHIMURIUM INVASION IN GOBLET CELLS
por: Gorman, H, et al.
Publicado: (2022)

The IgGFc-binding protein FCGBP is secreted with all GDPH sequences cleaved but maintained by interfragment disulfide bonds
por: Ehrencrona, Erik, et al.
Publicado: (2021)

Comprehensive Analysis of Tumor Immune Microenvironment Characteristics for the Prognostic Prediction and Immunotherapy of Oral Squamous Cell Carcinoma
por: Zhao, Yijie, et al.
Publicado: (2022)

CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Xiaoliang, et al.
Publicado: (2022)

AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma
por: Xiao, Jingchuan, et al.
Publicado: (2021)

HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma
por: Chen, Yan, et al.
Publicado: (2023)

CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma
por: Zhang, Yijian, et al.
Publicado: (2021)

Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for Immunotherapy
por: Lee, Yi-Mei, et al.
Publicado: (2023)

Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma
por: Yang, Zongcheng, et al.
Publicado: (2019)

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
por: Sun, Yawei, et al.
Publicado: (2021)

Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma
por: Romani, Chiara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_27ies1e8p6k6f5ugq37qql52d9